Post-approval studies (Phase 4)Study completedNCT00844857What this trial is testingAssessing Treatment of Patients Ages 10-17 With Bipolar DepressionWho this might be right forBipolar Depression Eli Lilly and Company 291
Testing effectiveness (Phase 2)Study completedNCT00374920What this trial is testingSafety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I DisorderWho this might be right forBipolar Disorder With Manic or Mixed Episodes Memory Pharmaceuticals 60
Large-scale testing (Phase 3)Study completedNCT05658510What this trial is testingDexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)Who this might be right forAgitation,PsychomotorBipolar I DisorderBipolar II Disorder+3 more BioXcel Therapeutics Inc 452
Large-scale testing (Phase 3)Enrolling By InvitationNCT07217860What this trial is testingAn Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)Who this might be right forBipolar DepressionBipolar I DisorderBipolar Disorder+1 more Xenon Pharmaceuticals Inc. 400
Not applicableUnknownNCT03192631What this trial is testingFinancial Incentives to Improve Acceptance of Antipsychotic InjectionsWho this might be right forSchizophreniaSchizo Affective DisorderBipolar I Disorder Focus Community Mental Health Team 20
Large-scale testing (Phase 3)Active Not RecruitingNCT06608641What this trial is testingEfficacy and Safety of Endoxifen in Bipolar I Disorder PatientsWho this might be right forBipolar 1 Disorder Jina Pharmaceuticals Inc. 490
Large-scale testing (Phase 3)Enrolling By InvitationNCT04987229What this trial is testingLong-term Safety Extension Study of OLZ/SAM in Pediatric SubjectsWho this might be right forBipolar I DisorderSchizophrenia Alkermes, Inc. 236
Post-approval studies (Phase 4)Study completedNCT00264173What this trial is testingVALID : VAlproate Versus LIthium in Bipolar DisordersWho this might be right forBipolar Disorder Sanofi 270
Large-scale testing (Phase 3)Ended earlyNCT04771299What this trial is testingAssessing the Role of Cariprazine in Improving Cognition in Euthymic Bipolar PatientsWho this might be right forBipolar I DisorderCognitive Impairment Lakshmi N Yatham 1
Testing effectiveness (Phase 2)Looking for participantsNCT06656416What this trial is testingALTO-100 in Bipolar Disorder With Depression (BD-D)Who this might be right forBipolar Disorder I or II With a Major Depressive Episode Alto Neuroscience 200
Not applicableUnknownNCT03603561What this trial is testingContinuous Theta Burst Stimulation as an add-on Treatment for Bipolar DepressionWho this might be right forBipolar DisorderBipolar DepressionBipolar I Disorder+4 more Universiteit Antwerpen 40
Testing effectiveness (Phase 2)Looking for participantsNCT07569198What this trial is testingKetamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)Who this might be right forBorderline Personality Disorder (BPD)Treatment-Resistant Major Depressive DisorderTreatment-resistant Bipolar Depression+4 more Joshua Rosenblat 120
Post-approval studies (Phase 4)Study completedNCT00181870What this trial is testingEquetro for the Treatment of Mania in Children Ages 6-12 With Bipolar DisorderWho this might be right forBipolar DisorderMania Massachusetts General Hospital 33
Testing effectiveness (Phase 2)Study completedNCT00322764What this trial is testingPhase II Study to Assess RG2417 in the Treatment of Bipolar I DepressionWho this might be right forBipolar Depression Repligen Corporation 80
Large-scale testing (Phase 3)Looking for participantsNCT06951711What this trial is testingEvaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)Who this might be right forBipolar Disorder Type I With Mania or Mania With Mixed Features Bristol-Myers Squibb 274
Large-scale testing (Phase 3)Study completedNCT00035230What this trial is testingA Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I DisorderWho this might be right forBipolar Disorder Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 338
Large-scale testing (Phase 3)Study completedNCT00391222What this trial is testingEvaluate the Efficacy and Safety of Risperidone for the Prevention of Mood Episodes in the Treatment of Patients With Bipolar I DisorderWho this might be right forBipolar Disorder Janssen Pharmaceutica N.V., Belgium 585
Testing effectiveness (Phase 2)Study completedNCT07116694What this trial is testingAssessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar DisorderWho this might be right forBipolar I DisorderBipolar II DisorderSchizophrenia+3 more BioXcel Therapeutics Inc 33
Post-approval studies (Phase 4)Study completedNCT00976794What this trial is testingEfficacy of Combined Treatment for Young Bipolar I DisorderWho this might be right forBipolar I Disorder University of Sao Paulo 40
Large-scale testing (Phase 3)Ended earlyNCT01122927What this trial is testingSafety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.Who this might be right forAdolescent SchizophreniaChild or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features Otsuka Pharmaceutical Development & Commercialization, Inc. 524